Metropolis Healthcare Ltd
Ticker: METROPOLIS
Decent
73/100
☆ Add to Watchlist
Investing Reference
Price
1941.70
Market Cap
10062.27
Debt/Equity
0.1529
ROE %
11.912
PB
7.5393
Promoter %
48.894
Pledge %
0.579
1Y Rev Growth %
10.641
5Y Rev Growth %
9.252
NP Margin %
10.767
NP Margin 5Y Avg %
13.731
Trading Reference
1M Return %
-5.023
6M Return %
18.036
1Y Return %
-14.067
% Away 52W High
17.889
% Away 52W Low
47.658
Daily Volume
87487
Investment Verdict
Risky
Score 52/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 37/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Metropolis Healthcare Ltd is currently trading near its support level, with the 50-day EMA indicating potential upward momentum. If it breaks above the resistance level, there is a strong probability of a price increase in the medium term. However, if it falls below the support, a decline is likely.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
N
Nippon India ETF Nifty Bank BeES
The Nippon India ETF Nifty Bank BeES shows decent potential with a stable sector outlook, but faces challenges in profitability and valuation metrics.
View details
S
Sonata Software Ltd
Sonata Software Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
I
INOX India Ltd
INOX India Ltd shows potential for growth in a promising sector, but faces challenges in profitability and valuation metrics.
View details
J
JK Lakshmi Cement Ltd
JK Lakshmi Cement Ltd shows decent fundamentals with growth potential, but faces challenges in profitability and execution risks.
View details
V
Vesuvius India Ltd
Vesuvius India Ltd shows decent potential but faces challenges in profitability and valuation metrics.
View details
S
Shakti Pumps (India) Ltd
Shakti Pumps shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
S
Sapphire Foods India Ltd
Sapphire Foods India Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should proceed with caution.
View details
H
HFCL Ltd
HFCL Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
T
Transrail Lighting Ltd
Transrail Lighting Ltd faces significant challenges in growth and profitability, with a weak market sentiment. Caution is advised for potential investors.
View details
T
Tejas Networks Ltd
Tejas Networks Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
G
Graphite India Ltd
Graphite India Ltd shows potential due to its positioning in a growing sector, but faces challenges in profitability and valuation metrics.
View details
B
Balrampur Chini Mills Ltd
Balrampur Chini Mills Ltd shows potential for growth but faces challenges in profitability and market volatility.
View details
R
Ramkrishna Forgings Ltd
Ramkrishna Forgings Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
B
Birlasoft Ltd
Birlasoft Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
A
Alkyl Amines Chemicals Ltd
Alkyl Amines Chemicals Ltd shows decent potential with growth opportunities, but faces challenges in profitability and valuation metrics.
View details
P
Procter & Gamble Health Ltd
Procter & Gamble Health Ltd shows decent fundamentals with growth potential, but faces challenges in profitability and valuation metrics.
View details
Business Overview
Metropolis Healthcare Ltd is a leading diagnostic service provider in India, dedicated to delivering high-quality laboratory services. Catering to patients, healthcare professionals, and institutions, Metropolis plays a crucial role in early disease detection and management. With a commitment to accuracy and reliability, it ensures timely results that empower informed healthcare decisions. Their extensive network of labs and advanced technology positions them as a trusted partner in health management.
- Leading diagnostic service provider in India
- Focus on high-quality laboratory services
- Supports early disease detection and management
- Trusted by patients and healthcare professionals
- Extensive network of labs across the country
- Commitment to accuracy and timely results
Investment Thesis
Metropolis Healthcare Ltd stands out as a compelling investment due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. The company's commitment to quality and innovation positions it well in the expanding healthcare sector.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services catering to modern healthcare needs.
- Attractive valuation offers a favorable entry point compared to industry peers.
- Established brand reputation in diagnostic services drives customer loyalty.
- Strategic expansion plans align with increasing demand for healthcare services.
Opportunity vs Risk
Opportunities
- Growing demand for diagnostic services
- Expansion into tier-2 cities
- Strong brand recognition
- Technological advancements in testing
- Potential for strategic partnerships
Risks ⚠️
- Intense competition in healthcare sector
- Regulatory changes impacting operations
- Economic downturn affecting consumer spending
- Dependence on skilled workforce
- Fluctuating raw material costs
Peer Perspective
Metropolis Healthcare Ltd trades at a premium compared to peers like Dr. Lal PathLabs and Thyrocare, reflecting its strong growth potential. A sustained improvement in margins could trigger a positive rerating in the stock.
Future Outlook
Metropolis Healthcare Ltd is well-positioned for growth, driven by expanding services and a strong market presence. However, successful execution and effective cost control will be crucial to fully realize its potential.
AI FAQs for Retail Users
- Q: What does Metropolis Healthcare Ltd do?A: Metropolis Healthcare Ltd is a leading diagnostic service provider in India, offering a wide range of tests.
- Q: Is Metropolis Healthcare Ltd a profitable company?A: The company has shown profitability in recent years, but past performance does not guarantee future results.
- Q: What are the growth prospects for Metropolis Healthcare Ltd?A: Growth prospects depend on market conditions, demand for healthcare services, and company strategies.
- Q: How can I invest in Metropolis Healthcare Ltd?A: You can invest through a stockbroker or trading platform that offers access to Indian stock markets.
- Q: What are the risks of investing in Metropolis Healthcare Ltd?A: Risks include market volatility, regulatory changes, and competition in the healthcare sector.
📊 Stock Investment Checklist (100 Points)
Metropolis Healthcare Ltd • Updated: 2025-09-18 07:21:22
-
10BusinessHighHealthcare sector is future-ready with a clear model and moderate moat.
-
10GrowthHighConsistent revenue growth but profit growth shows some volatility.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is lower than net profit.
-
10ValuationHighP/E and P/B ratios are slightly above peers, indicating overvaluation.
-
8BalanceHighDebt/equity ratio is manageable, but liquidity could be improved.
-
7GovernanceHighPromoter holding is strong, but there are some concerns about pledging.
-
6DriversGoodGrowth catalysts exist, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is mixed with low liquidity.
Final Score & Verdict
Score 73 / 100
• Decent
Metropolis Healthcare Ltd shows potential for growth, but investors should be cautious due to valuation concerns and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 75/100